Your browser doesn't support javascript.
loading
The Role of In Vivo and Ex Vivo Diagnostic Tools in Severe Delayed Immune-Mediated Adverse Antibiotic Drug Reactions.
Copaescu, Ana; Mouhtouris, Effie; Vogrin, Sara; James, Fiona; Chua, Kyra Y L; Holmes, Natasha E; Douglas, Abby; Slavin, Monica A; Cleland, Heather; Zubrinich, Celia; Aung, Ar Kar; Goh, Michelle S Y; Phillips, Elizabeth J; Trubiano, Jason A.
Afiliação
  • Copaescu A; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia; Clinical Immunology and Allergy, McGill University Health Center, Montréal, QC, Canada. Electronic address: ana.copaescu@gmail.com.
  • Mouhtouris E; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia.
  • Vogrin S; Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, VIC, Australia.
  • James F; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia.
  • Chua KYL; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia.
  • Holmes NE; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia; Department of Medicine and Radiology, Melbourne Medical School, The University of Melbourne, Parkville, VIC, Australia.
  • Douglas A; Department of Infectious Diseases and Infection Prevention, Peter MacCallum Cancer Centre, The University of Melbourne, Parkville, VIC, Australia; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, VIC, Australia; Department of Oncology, Peter MacCallum Cancer Ce
  • Slavin MA; Department of Infectious Diseases and Infection Prevention, Peter MacCallum Cancer Centre, The University of Melbourne, Parkville, VIC, Australia; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, VIC, Australia; Department of Oncology, Peter MacCallum Cancer Ce
  • Cleland H; Burns Unit, Alfred Health, Melbourne, VIC, Australia.
  • Zubrinich C; Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Aung AK; Department of General Medicine, Alfred Health, Melbourne, VIC, Australia.
  • Goh MSY; Department of Dermatology, Austin Health, Heidelberg, VIC, Australia; Department of Dermatology, Alfred Health, Melbourne, VIC, Australia; Department of Dermatology, St Vincent's Hospital, Fitzroy, VIC, Australia.
  • Phillips EJ; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia; Department of Infectious Diseases, Vanderbilt University Medical Centre, Nashville, Tenn.
  • Trubiano JA; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, VIC, Australia; Department of Oncology, Peter MacCallum Cancer Centre, The University of M
J Allergy Clin Immunol Pract ; 9(5): 2010-2015.e4, 2021 05.
Article em En | MEDLINE | ID: mdl-33453452

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Síndrome de Stevens-Johnson / Pustulose Exantematosa Aguda Generalizada Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Síndrome de Stevens-Johnson / Pustulose Exantematosa Aguda Generalizada Idioma: En Ano de publicação: 2021 Tipo de documento: Article